Celltech
Celltech was a pioneering biotechnology company based in the United Kingdom. Founded in 1980, it was one of the first biotechnology companies in Europe and played a significant role in the development of the biotechnology industry in the UK.
History[edit]
Celltech was established in 1980 by a group of scientists and entrepreneurs who recognized the potential of biotechnology to transform medicine and healthcare. The company initially focused on the development of monoclonal antibodies and other innovative therapeutic approaches.
In the 1990s, Celltech expanded its research and development efforts, entering into collaborations with major pharmaceutical companies to advance its drug discovery programs. The company became known for its work in immunology and oncology, developing several promising drug candidates.
Acquisitions and Mergers[edit]
In 1999, Celltech acquired Chiroscience, another UK-based biotechnology company, which helped to strengthen its position in the industry. This acquisition was part of a broader strategy to expand its capabilities and pipeline.
In 2004, Celltech itself was acquired by the Belgian pharmaceutical company UCB. This acquisition marked the end of Celltech as an independent entity, but its legacy continued as part of UCB's global operations.
Contributions to Biotechnology[edit]
Celltech made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. The company's research efforts led to the discovery of several important therapeutic agents that have been used in the treatment of various diseases.
The company's work in biopharmaceuticals helped to establish the UK as a leader in the biotechnology sector, paving the way for future innovations and developments in the field.
Legacy[edit]
Although Celltech no longer exists as an independent company, its impact on the biotechnology industry is still felt today. The company's pioneering efforts in drug discovery and development have influenced many of the current practices and technologies used in the field.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian